EP #143 | Swedish Dividend Growth Stocks with strong track records! | $JNJ Settlement
Dividend Talk
00:00
Johnson & Johnson Settlement
I think it's a reasonable deal. The victims, the patients, they get compensation. But it always makes me think again about this jury system that they have in the states. So there is no scientific evidence. That's what Johnson & Johnson claims. For me, because we don't know the sciences retail investors, it's really hard to judge who's right and who's not right.
Transcript
Play full episode
